Navigation Links
The Outlook for Pharmaceuticals in Central & Eastern Europe
Date:12/13/2012

d Nycomed that gives the latter exclusive rights to commercialise MoviPrep in Russia; investment by Rusnano, Russia's government investment company, in Cleveland BioLabs' new subsidiary, Panacela Labs, which will develop a portfolio of new preclinical drug candidates in Russia; Pfizer and ChemRar High Technology Centre signing a memorandum of understanding to explore a collaboration focused on the research, development and commercialisation of innovative drugs in Russia; and the launching of Pro Bono Bio as a new international pharmaceutical company as a result of a three-year Anglo/Russian project.

UKRAINE

In June 2011, the Cabinet of Ministers adopted the state target scientific-technical programme for the development of new technologies to create domestic pharmaceuticals, which is designed to meet the human and veterinary medicinal needs of 2011-2015. State funding will account for almost half of the budget for the programme. A quarter of state funding will be used for the research & development of molecular and cellular technologies for creating biologically active substances. Investment funds will be used primarily to purchase modern equipment for the production of innovative medicinal substances, including immunological agents, vaccines and recombinant proteins.

THESE REPORTS ANALYSE THE ISSUES The The Outlook for Pharmaceuticals in Central & Eastern Europe is a unique collection of management reports from Espicom Business Intelligence. Each report provides individual and highly-detailed analysis of each market, looking at the key regulatory, political, economic and corporate developments in the wider context of market structure, service and access. The reports are available individually, or as a discounted collection, and prices include 4 completely updated reports sent quarterly, together with a comprehensive statistical appendix. There are over 60 markets covered in the worldwide series.

To order this report:

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. CVS Caremark Provides Strong Growth Outlook for 2013 and Beyond, Announces 38%Dividend Increase and Outlines Strategic Growth Framework
2. World Diagnostic Imaging Market Outlook and Leading Suppliers Business Strategies and Marketing Tactics
3. Cytos Biotechnology Ltd Reports Third Quarter 2012 Financial Results, Recent Development and Outlook
4. South and Central America Patient Monitoring Market Outlook to 2018 - Fetal Monitors, Multiparameter Patient Monitoring, Neonatal Monitors, Non-Invasive Blood Pressure Monitors and Others
5. PDI, Inc. Announces New Multi-Year Win Valued At up to $150 Million and Provides Outlook for 2012
6. Japan Pharma Review: Outlook to 2017
7. South and Central America Orthopedic Devices Market Outlook to 2018 - Arthroscopy, Cranio Maxillofacial Fixation (CMF), Hip Reconstruction, Knee Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others
8. Peripheral Vascular Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018
9. Orthopedic Braces and Supports Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018
10. China Digital Radiography (DR) Market Assessment and Outlook 2012-2015
11. Brazil Orthopedic Devices Market Outlook to 2018 - Arthroscopy, Cranio Maxillofacial Fixation (CMF), Hip Reconstruction, Knee Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... Texas , Sept. 4, 2015  Luminex Corporation ... present at the Morgan Stanley Global Healthcare Conference to ... Grand Hyatt Hotel in New York City ... at 11:40 a.m. Eastern time on Friday, September 18, ... accessed at Luminex Corporation,s website at http://www.luminexcorp.com . ...
(Date:9/4/2015)... SOUTH PLAINFIELD, N.J. , Sept. 4, 2015 ... is pleased to announce five recipients of its ... to Realize Innovation, Vision and Empowerment), designed to ... the Duchenne muscular dystrophy (DMD) community. The announcement ... for the international World Duchenne Awareness Day on ...
(Date:9/4/2015)... Future Prospects for Companies in ... Rhinitis drugs - new study showing you trends, ... market for allergic rhinitis drugs heading? What are the ... report shows you potential revenues and other trends to ... 326 page report provides 273 tables, charts, and graphs. ...
Breaking Medicine Technology:Luminex Corporation To Present At The Morgan Stanley Global Healthcare Conference 2PTC Therapeutics Announces Five Winners In Its First-ever Global Duchenne Muscular Dystrophy Patient Group Award 2PTC Therapeutics Announces Five Winners In Its First-ever Global Duchenne Muscular Dystrophy Patient Group Award 3PTC Therapeutics Announces Five Winners In Its First-ever Global Duchenne Muscular Dystrophy Patient Group Award 4Allergic Rhinitis Drugs Market Forecast 2015-2025 2Allergic Rhinitis Drugs Market Forecast 2015-2025 3Allergic Rhinitis Drugs Market Forecast 2015-2025 4Allergic Rhinitis Drugs Market Forecast 2015-2025 5Allergic Rhinitis Drugs Market Forecast 2015-2025 6Allergic Rhinitis Drugs Market Forecast 2015-2025 7
... , EXTON, Pa., Oct. 9 Kensey Nash ... release its earnings results for its first quarter ended September ... 22, 2009. , Joe Kaufmann, President and CEO, ... Thursday, October 22, 2009 at 9:00 A.M. Eastern Time. ...
... 9 ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX ... announced sale of shares of its Series D convertible ... institutional investors, representing gross proceeds to ADVENTRX of approximately ... from the offering to fund its operations during the ...
Cached Medicine Technology:Kensey Nash Corporation Announces Its First Quarter Fiscal Year 2010 Earnings Release Date and Teleconference 2ADVENTRX Pharmaceuticals Announces Closing of Financing 2ADVENTRX Pharmaceuticals Announces Closing of Financing 3
(Date:9/4/2015)... ... September 04, 2015 , ... Scalability Experts ... the Year” awards at this year’s Microsoft Worldwide Partner Conference that was held ... the Year” Award Winner for Data Platform services, the 2015 HP and Microsoft ...
(Date:9/4/2015)... Francisco, CA (PRWEB) , ... September 04, 2015 ... ... Amini, announces that CEREC technology is now available at CitiDent. CEREC is a ... machinery. In addition to saving time for patients by eliminating the need for ...
(Date:9/4/2015)... , ... September 04, 2015 , ... Mike Day, a ... 2007, will compete in the Ironman World Championships in Kona on October 10th. , ... incurred Traumatic Brain Injury (TBI) through combat and the cutting-edge treatments that restore their ...
(Date:9/4/2015)... ... September 04, 2015 , ... Bio-Logic Aqua® Research, a ... announced its only mission and research focus: Water Life Science®. In the current ... water evaporation is becoming dangerously accelerated. As a result of the global fresh ...
(Date:9/4/2015)... ME (PRWEB) , ... September 04, 2015 , ... ... focus on: the microbiome taking place in Hollywood, Florida October 9-10, 2015 at ... , Speakers at the 2015 symposium are doctors and researchers at the top ...
Breaking Medicine News(10 mins):Health News:Scalability Experts is Awarded Three Separate 2015 “Partner of the Year” Awards at Microsoft’s Worldwide Partner Conference 2Health News:Scalability Experts is Awarded Three Separate 2015 “Partner of the Year” Awards at Microsoft’s Worldwide Partner Conference 3Health News:Scalability Experts is Awarded Three Separate 2015 “Partner of the Year” Awards at Microsoft’s Worldwide Partner Conference 4Health News:San Francisco Dentist, Dr. Ben Amini, is Now Offering CEREC Technology at CitiDent 2Health News:Navy SEAL Shot 27 Times Competes in Ironman World Championship in Kona to Raise Money for Veteran's Suffering from TBI and PTSD 2Health News:Bio-Logic Aqua® Research Announces Water Life Science and Body Water Evaporation as Research Focus and Mission 2Health News:Bio-Logic Aqua® Research Announces Water Life Science and Body Water Evaporation as Research Focus and Mission 3Health News:Integrative Healthcare Symposium Focus On: The Microbiome Conference Program Announced 2
... 22-hour procedure replaced 80% of severely disfigured woman,s face, ... A team of eight Cleveland Clinic surgeons has completed ... most of the woman,s face, including about 80 percent ... most of the sinuses, upper jaw -- essentially ...
... Calif., Dec. 17 Human Pheromone,Sciences, Inc. (OTC Bulletin ... filed a Comprehensive Patent Application with the U.S. Patent ... previously undeveloped,compound with its origin in sea coral, which ... feelings of positive social relationships,personal well-being and social attraction. ...
... LLC today announced positive results from a Phase 2 ... Multiple Sclerosis patients with documented cognitive dysfunction. , ... study, Cognition Pharmaceuticals reported, the active group obtained significantly ... learning, including the Brief Visuospatial Memory Test - Revised, ...
... Jude Children,s Research Hospital have answered a central question ... rise to tumors. Stem cells are immature cells that ... cells that compose the range of body tissues. In ... arise from mutant forms of stem cells. , ...
... Dec. 17 Time Life is proud to announce they have teamed ... a brand new fitness program set to dance hits of the ,70s, ... , Cheryl Burke has been dancing since the age ... titles around the world. For the past six television seasons, the ...
... Mass., Dec. 17 Hologic, Inc. (Nasdaq: HOLX ... medical imaging systems and surgical products dedicated to serving the ... first quarter fiscal 2009 operating results on Monday, February 2, ... will host a conference call on Monday, February 2, 2009 ...
Cached Medicine News:Health News:Doctors Describe First U.S. Face Transplant 2Health News:Doctors Describe First U.S. Face Transplant 3Health News:Doctors Describe First U.S. Face Transplant 4Health News:HPS Files Patent for Mood-Enhancing Compound Naturally Found in Sea Coral 2Health News:Cognition Pharmaceuticals Announces Positive Memory Results for Phase II Trial of C105 in Multiple Sclerosis 2Health News:Cognition Pharmaceuticals Announces Positive Memory Results for Phase II Trial of C105 in Multiple Sclerosis 3Health News:Cognition Pharmaceuticals Announces Positive Memory Results for Phase II Trial of C105 in Multiple Sclerosis 4Health News:Molecular marker identifies normal stem cells as intestinal tumor source 2Health News:Cheryl Burke of 'Dancing with the Stars' Joins Forces With Time Life To Create a Brand New Dance Workout, 'DISCO ABS' 2Health News:Cheryl Burke of 'Dancing with the Stars' Joins Forces With Time Life To Create a Brand New Dance Workout, 'DISCO ABS' 3Health News:Hologic, Inc. to Release First Quarter Fiscal 2009 Operating Results on Monday, February 2, 2009 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: